All AbMole products are for research use only, cannot be used for human consumption.
BMS-599626 (AC480) is an orally bioavailable inhibitor of the HER1, HER2 and HER4 tyrosine kinases (IC50=22, 32 and 190 nM, respectively), thereby inhibiting the proliferation of tumor cells that overexpress these receptors.
| Cell Experiment | |
|---|---|
| Cell lines | Sal2 mouse salivary gland tumor cells, .KPL-4 cells and PC9 cells |
| Preparation method | Cell assay. All cell lines were maintained in RPMI 1640 supplemented with 10% fetal bovine serum, 100 units/mL penicillin, and 100 Ag/mL streptomycin. Cells were plated at 1,000 per well in 96-well plates and were cultured for 24 hours before test compounds were added.Compounds were diluted in culture medium such that the final concentration of DMSO never exceeded 1%.Following the addition of compounds, the cells were cultured for an additional 72 hours before cell viability was determined by measuring the conversion of 3-(4,5-dimethylthiazol- 2-yl)-2,5-diphenyltetrazolium bromide dye with the CellTiter96 kit (Promega, Madison, WI). |
| Concentrations | 0~10µM |
| Incubation time | 72 h |
| Animal Experiment | |
|---|---|
| Animal models | SAL2 murine salivary gland tumor, mice bearing KPL-4 human breast tumors and GEO human colon tumor models |
| Formulation | dissolved in a mixture of propylene glycol/water (50:50) |
| Dosages | SAL2: 60, 120, 240 mg/kg daily for 14 days(d10-24); GEO human colon tumors：120,180mg/ kg daily for 14 days(d10-24);mice bearing KPL-4 human breast tumors: once daily for 21days) at 60 mg/kg and 180 mg/kg |
| Administration | oral |
| Molecular Weight | 567.01 |
| Formula | C27H27FN8O3.HCl |
| CAS Number | 8173837-23-1 |
| Solubility (25°C) | DMSO |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Related EGFR/HER2 Products |
|---|
| AEE788
AEE788 (NVP-AEE788) is a novel multitargeted HER 1/2 and VEGFR 1/2 receptor family tyrosine kinases inhibitor with IC50 of 2, 6, 77, 59 nM for EGFR, ErbB2, KDR, and Flt-1. |
| Sapitinib (AZD8931)
AZD8931 (Sapitinib) is an equipotent, reversible inhibitor of Signaling by EGFR, ERBB2 (HER2), and ERBB3 with IC50 of 4, 3, 4 nM respectively. |
| Afatinib
Afatinib (BIBW 2992) is a novel irreversible dual EGFR and HER2 tyrosine kinase inhibitor. |
| CP-724714
CP-724714 is a potent and selective orally active HER-2 tyrosine kinase inhibitor, IC50 = 3 nM. |
| Erlotinib Hydrochloride
Erlotinib is an inhibitor of human EGFR tyrosine kinase (IC50 = 2 nM) and decreases EGFR autophosphorylation in tumor cells (IC50 = 20 nM). |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
